The Innovation Center for Basic Research in Inflammation and Immune-Related Diseases, Ministry of Education is a joint initiative established by Lewwin Pharm and Southern Medical University. This platform provides a comprehensive range of non-clinical evaluation and research services for anti-infective drugs. To date, it has completed pharmacological efficacy studies and safety evaluations for over 30 anti-infective drugs, securing nearly 20 clinical trial approvals, including seven Class 1 innovative drugs. Notably, among these is a Class 1.1 innovative drug approved for the treatment of dry eye and ocular inflammation.